76
Views
0
CrossRef citations to date
0
Altmetric
Research Article

“Saving us to Death”: Ideology and Communicative (Dis)enfranchisement in Misapplications of the 2016 CDC Opioid Prescribing Guidelines

ORCID Icon & ORCID Icon

References

  • Agnoli, A., Xing, G., Tancredi, D. J., Magnan, E., Jerant, A., & Fenton, J. J. (2021). Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA, 326(5), 411–419. https://doi.org/10.1001/jama.2021.11013
  • Allen, J. (2019). What’s the big “D”? Contemporary approaches to discourse in interpersonal and family communication scholarship. Communication Theory, 29(1), 107–127. https://doi.org/10.1093/ct/qty012
  • American Medical Association [AMA]. (2018). Report of reference committee B – annotated. https://www.ama-assn.org/system/files/2018-11/i18-refcomm-b-annotated.pdf
  • Antoniou, T., Ala-Leppilampi, K., Shearer, D., Parsons, J. A., Tadrous, M., & Gomes, T. (2019). “Like being put on an ice floe and shoved away”: A qualitative study of the impacts of opioid-related policy changes on people who take opioids. International Journal of Drug Policy, 66(1), 15–22. https://doi.org/10.1016/j.drugpo.2019.01.015
  • Applequist, J. (2016). Broadcast pharmaceutical advertising in the United States: Primetime pill pushers. Lexington Books.
  • August-Rae, B. C., Baker, J. T., & Buzzanell, P. M. (2024). “Not just rebellious, it’s revolutionary”: Do-it-yourself hormone replacement therapy as liberatory harm reduction. Social Science & Medicine, 345, 116681. https://doi.org/10.1016/j.socscimed.2024.116681
  • Baker, J. T., Cusanno, B. R., & Dean, M. (2023). Dilemmas in patient-clinician communication about do-it-yourself hormone therapy: A qualitative study. SSM-Qualitative Research in Health, 3(1), 100213. https://doi.org/10.1016/j.ssmqr.2022.100213
  • Bertrand, S., Meynet, G., Taffé, P., Della Santa, V., Fishman, D., Fournier, Y., Frochaux, V., Ribordy, V., Rutschmann, O. T., & Hugli, O. (2021). Opiophobia in emergency department healthcare providers: A survey in western Switzerland. Journal of Clinical Medicine, 10(7), 1353. https://doi.org/10.3390/jcm10071353
  • Bettinger, J. J., Amarquaye, W., Fudin, J., & Schatman, M. E. (2022). Misinterpretation of the “overdose crisis” continues to fuel misunderstanding of the role of prescription opioids. Journal of Pain Research, 15(1), 949–958. https://doi.org/10.2147/JPR.S367753
  • Brashers, D. E., Haas, S. M., & Neidig, J. L. (1999). The patient self-advocacy scale: Measuring patient involvement in health care decision-making interactions. Health Communication, 11(2), 97–121. https://doi.org/10.1207/s15327027hc1102_1
  • Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
  • Braun, V., & Clarke, V. (2019). Reflecting on reflexive thematic analysis. Qualitative Research in Sport, Exercise and Health, 11(4), 589–597. https://doi.org/10.1080/2159676X.2019.1628806
  • Capodilupo, R., & Rich, J. J. (2023). The misinformed & misguided prescription abuse prevention act: A response to delfino. Yale Law and Policy Review, 1(1), 1–17. https://yalelawandpolicy.org/inter_alia/misinformed-misguided-prescription-abuse-prevention-act-response-delfino
  • Centers for Disease Control and Prevention [CDC]. (2016). About CDC’s opioid prescribing guideline. https://www.cdc.gov/opioids/providers/prescribing/guideline.html
  • Centers for Disease Control and Prevention [CDC]. (2017). Prescription opioids. https://www.cdc.gov/opioids/basics/prescribed.html
  • Centers for Disease Control and Prevention [CDC]. (2018). Process for updating the opioid prescribing guIdeline. https://www.cdc.gov/opioids/guideline-update-index.html
  • Centers for Disease Control and Prevention [CDC]. (2019). CDC advises against misapplication of the guideline for prescribing opioids for chronic pain. https://www.cdc.gov/media/releases/2019/s0424-advises-misapplication-guideline-prescribing-opioids.html
  • Centers for Disease Control and Prevention [CDC]. (2020). Overdose deaths accelerating during COVID-19. https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html
  • Centers for Disease Control and Prevention [CDC]. (2022). CDC clinical practice guideline for prescribing opioids for pain – United States, 2022. https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm
  • Centers for Disease Control and Prevention [CDC]. (2023). Training for healthcare professionals. https://www.cdc.gov/opioids/healthcare-professionals/training/index.html
  • Centers for Disease Control and Prevention [CDC]. (2024a). Commonly used terms. https://www.cdc.gov/opioids/basics/terms.html
  • Centers for Disease Control and Prevention [CDC]. (2024b). Prescription drug monitoring programs. https://www.cdc.gov/drugoverdose/pdmp/index.html
  • Centers for Disease Control and Prevention [CDC]. (2024c). Process for the development of the 2022 clinical practice guideline for prescribing opioids for pain. https://www.cdc.gov/opioids/guideline-update/index.html
  • Centers for Disease Control and Prevention [CDC]. (2024d). Understanding the epidemic. https://www.cdc.gov/opioids/basics/epidemic.html
  • Charalambous, A., Zorpas, M., Cloconi, C., & Kading, Y. (2019). Healthcare professionals’ perceptions on the use of opioid analgesics for the treatment of cancer-related pain in Cyprus: A mixed-method study. SAGE Open Medicine, 7(1), 1–18. https://doi.org/10.1177/2050312119841823
  • Dassieu, L., Heino, A., Develay, É., Kaboré, J. L., Pagé, M. G., Moor, G., Hudspith, M., & Choinière, M. (2021). “They think you’re trying to get the drug”: Qualitative investigation of chronic pain patients’ health care experiences during the opioid overdose epidemic in Canada. Canadian Journal of Pain, 5(1), 66–80. https://doi.org/10.1080/24740527.2021.1881886
  • Donovan, E. E., & Hazlett, A. D. (2024). The labor of communicatively coping: Toward an integrative theory of communication work. Human Communication Research, 50(2), 230–239. https://doi.org/10.1093/hcr/hqad049
  • Don’t Punish Pain Rally. (2017). About DPPR. https://dontpunishpainrally.com/about-dppr/
  • Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA, 315(15), 1624–1645. https://doi.org/10.1001/jama.2016.1464
  • Fenton, J. J., Agnoli, A. L., Xing, G., Hang, L., Altan, A. E., Tancredi, D. J., Jerant, A., & Magnan, E. (2019). Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008–2017. JAMA Open, 2(11), e1916271. https://doi.org/10.1001/jamanetworkopen.2019.16271
  • Flemmen, A. B. (2018). Sensitizing concepts in action: Expanding the framework. In H. Leiulfsrud & P. Sohlberg (Eds.), Concepts in action: Conceptual constructionism (pp. 79–94). Brill.
  • Giddens, A. (1984). The constitution of society: Outline of the theory of structuration. Blackwell/Polity Press.
  • Goldberg, D. S., & McGee, S. J. (2011). Pain as a global public health priority. BMC Public Health, 11(1), 770. https://doi.org/10.1186/1471-2458-11-770
  • Gunning, J. N., Romann, L. R., & Hintz, E. A. (2024). Framing chronic pain in U.S. news coverage of the opioid epidemic (2012-2022). Health Communication. Advance online publication. https://doi.org/10.1080/10410236.2024.2304494
  • Gunning, J. N., & Taladay-Carter, C. (2023). Grieving “the death of possibility”: Memorable messages of (dis) enfranchised loss in invisible, physical illness. Health Communication. Advance online publication. https://doi.org/10.1080/10410236.2023.2257942
  • Hall, S. (1996). The problem of ideology: Marxism without guarantees. In D. Morley & K. Chen (Eds.), Stuart Hall: Critical dialogues in cultural studies (pp. 24–45). Routledge.
  • Hintz, E. A. (2020). Pain communication: An agenda for communication researchers. Annals of the International Communication Association, 44(4), 401–421. https://doi.org/10.1080/23808985.2020.1843368
  • Hintz, E. A., & Applequist, J. (2023). E-sisters and the case of the essure coil: Power, representation, and voice in women’s public docket accounts to the FDA of medical device adverse events. Journal of Applied Communication Research, 51(5), 500–518. https://doi.org/10.1080/00909882.2023.2179417
  • Hintz, E. A., & Betts, T. (2022). Reddit in communication research: Current status, future directions, and best practices. Annals of the International Communication Association, 46(2), 116–133. https://doi.org/10.1080/23808985.2022.2064325
  • Hintz, E. A., & Scharp, K. M. (2024). Theory of communicative (dis) enfranchisement: Introduction, explication, and application. Journal of Communication, 74(2), 89–100. https://doi.org/10.1093/joc/jqae002
  • Hintz, E. A., & Tucker, R. V. (2023). Contesting illness: Communicative (dis)enfranchisement in patient–provider conversations about chronic overlapping pain conditions. Human Communication Research, 49(2), 170–181. https://doi.org/10.1093/hcr/hqad004
  • Institute of Medicine [IOM]. (2011). Relieving pain in America: A blueprint for transforming prevention, care, education, and research. National Academies Press.
  • Kertesz, S. G., McCullough, M. B., Darnall, B. D., & Varley, A. L. (2020). Promoting patient-centeredness in opioid deprescribing: A blueprint for de-implementation science. Journal of General Internal Medicine, 35(3), 972–977. https://doi.org/10.1007/s11606-020-06254-7
  • King, N. B., & Fraser, V. (2013). Untreated pain, narcotics regulation, and global health ideologies. PloS Medicine, 10(4), e1001411. https://doi.org/10.1371/journal.pmed.1001411
  • Koesling, D., & Bozzaro, C. (2021). Chronic pain patients’ need for recognition and their current struggle. Medicine, Health Care, and Philosophy, 24(4), 563–572. https://doi.org/10.1007/s11019-021-10040-5
  • Lagisetty, P., Macleod, C., Thomas, J., Slat, S., Kehne, A., Heisler, M., Bohnert, A. S. B., & Bohnert, K. M. (2021). Assessing reasons for decreased primary care access for individuals on prescribed opioids: An audit study. Pain, 162(5), 1379–1386. https://doi.org/10.1097/j.pain.0000000000002145
  • Lannamann, J. W. (1991). Interpersonal communication research as ideological practice. Communication Theory, 1(3), 179–203. https://doi.org/10.1111/j.1468-2885.1991.tb00014.x
  • Lapinski, M. K., & Orbe, M. P. (2007). Evidence for the construct validity and reliability of the co-cultural theory scales. Communication Methods and Measures, 1(2), 137–164. https://doi.org/10.1080/19312450701399388
  • Lawless, B., & Chen, Y. (2019). Developing a method of critical thematic analysis for qualitative communication inquiry. Howard Journal of Communications, 30(1), 92–106. https://doi.org/10.1080/10646175.2018.1439423
  • Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Sage.
  • Llorente, E. (2018). As doctors taper or end opioid prescriptions, many patients driven to despair, suicide. https://www.foxnews.com/health/as-opioids-become-taboo-doctors-taper-down-or-abandon-pain-patients-driving-many-to-suicide
  • Matthias, M. S. (2020). Opioid tapering and the patient-provider relationship. Journal of General Internal Medicine, 35(1), 8–9. https://doi.org/10.1007/s11606-019-05337-4
  • Matthias, M. S., Johnson, N. L., Shields, C. G., Bair, M. J., MacKie, P., Huffman, M., & Alexander, S. C. (2017). “I’m not gonna pull the rug out from under you”: Patient-provider communication about opioid tapering. The Journal of Pain, 18(11), 1365–1373. https://doi.org/10.1016/j.jpain.2017.06.008
  • Matthias, M. S., Talib, T. L., & Huffman, M. A. (2020). Managing chronic pain in an opioid crisis: What is the role of shared decision-making? Health Communication, 35(10), 1239–1247. https://doi.org/10.1080/10410236.2019.1625000
  • MAXQDA. (2022). Introducing MAXQDA 2020. https://www.maxqda.com/new-maxqda-2020
  • Pergolizzi, J. V., Rosenblatt, M., & LeQuang, J. A. (2019). Three years down the road: The aftermath of the CDC guideline for prescribing opioids for chronic pain. Advances in Therapy, 36(6), 1235–1240. https://doi.org/10.1007/s12325-019-00954-1
  • Prinja, S. (2010). Role of ideas and ideologies in evidence-based health policy. Iranian Journal of Public Health, 39(1), 64–69. https://doi.org/10.1186/1471-2458-4-55
  • Reddit. (2024). /r/Chronicpain. https://www.reddit.com/r/ChronicPain/
  • Ruben, M. A., & Hall, J. A. (2016). A lens model approach to the communication of pain. Health Communication, 31(8), 934–945. https://doi.org/10.1080/10410236.2015.1020261
  • Scott, K. D., Hintz, E. A., & Harris, T. M. (2022). “Having pain is normal”: How talk about chronic pelvic and genital pain reflects messages from menarche. Health Communication, 37(3), 296–306. https://doi.org/10.1080/10410236.2020.1837464
  • Sedney, C. L., Haggerty, T., Dekeseredy, P., Nwafor, D., Caretta, M. A., Brownstein, H. H., & Pollini, R. A. (2022). “The DEA would come in and destroy you”: A qualitative study of fear and unintended consequences among opioid prescribers in WV. Substance Abuse Treatment, Prevention, and Policy, 17(1), 19. https://doi.org/10.1186/s13011-022-00447-5
  • Sendra, A., & Farré, J. (2020). Communicating the experience of chronic pain through social media: Patients’ narrative practices on instagram. Journal of Communication in Healthcare, 13(1), 46–54. https://doi.org/10.1080/17538068.2020.1752982
  • SocialChamp. (2024). Important reddit stats you need to know in 2024. https://www.socialchamp.io/blog/reddit-stats/
  • Sullivan, M. D. (2021). Opioid deprescribing guidelines and consumer preferences: Betwixt and between. Pain, 162(11), 2625–2626. https://doi.org/10.1097/j.pain.0000000000002271
  • Thompson, C. M., Babu, S., & Makos, S. (2023a). A grounded theory of credibility work and illness: Explication and application to the case of women on trial in health care. Communication Research. Advance online publication. https://doi.org/10.1177/00936502231184318
  • Thompson, C. M., Babu, S., & Makos, S. (2023b). Women’s experiences of health-related communicative disenfranchisement. Health Communication, 38(14), 3135–3146. https://doi.org/10.1080/10410236.2022.2137772
  • U.S. Drug Enforcement Administration [DEA]. (2024). Facts about fentanyl. https://www.dea.gov/resources/facts-about-fentanyl
  • U.S. Food and Drug Administration [FDA]. (2019). FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. https://www.fda.gov/drugs/drug-safety-and-availability/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label-changes?utm_campaign=FDA%20MedWatch-Opioid%20Pain%20Medicines%3A%20Drug%20Safety%20Communication&utm_medium=email&utm_source=Eloqua
  • Vaglienti, R. (2018). Overview of SB 273 2018 opioid reduction act. https://www.wvctsi.org/media/12920/sb-273-opioid-reduction-act.pdf
  • Voorhees, H. L. (2023). “I was literally just not myself”: How chronic pain changes multiple frames of identity. Health Communication, 38(8), 1641–1653. https://doi.org/10.1080/10410236.2022.2025702
  • Webster, F., Rice, K., Katz, J., Bhattacharyya, O., Dale, C., Upshur, R., & Koester, S. (2019). An ethnography of chronic pain management in primary care: The social organization of physicians’ work in the midst of the opioid crisis. PLOS ONE, 14(5), e0215148. https://doi.org/10.1371/journal.pone.0215148

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.